Indications for Furosemide Therapy
Furosemide is primarily indicated for patients with symptoms secondary to congestion and volume overload, particularly in acute heart failure. 1
Primary Indications
Acute Heart Failure with Congestion
- Presence of pulmonary congestion
- Peripheral edema
- Signs of volume overload
- Dyspnea related to fluid retention
Chronic Heart Failure Management
- To maintain euvolemia in patients with history of fluid retention
- For patients who cannot maintain target weight without diuretic therapy 1
Dosing Considerations
Initial Dosing
- For IV administration: 20-40 mg bolus initially 1
- For oral administration: 20-40 mg once or twice daily (maximum 600 mg/day) 1
- For patients previously on furosemide: Consider starting at 2× the home oral dose 2
Dose Titration
- Assess response frequently in initial phase
- Monitor urine output (bladder catheterization may be helpful)
- Increase dose if inadequate response by approximately doubling the dose 2
- Total dose should remain <100 mg in first 6 hours and <240 mg during first 24 hours 1
Monitoring Requirements
Fluid Status
- Daily weight measurements
- Clinical assessment of congestion
- Urine output
Laboratory Parameters
Contraindications and Cautions
Relative Contraindications
- Hypotension (SBP <90 mmHg)
- Severe hyponatremia
- Acidosis 1
Adverse Effects to Monitor
Management Strategies for Diuretic Resistance
Increase Dose
- If initial response inadequate, increase dose according to renal function and history of chronic diuretic use 1
Consider Continuous Infusion
- May be more effective than bolus dosing in some patients 1
Add Second Diuretic
Special Considerations
Renal Impairment
Elderly Patients
Diabetic Patients
Furosemide remains a cornerstone therapy for managing fluid overload in heart failure, with significant symptomatic benefits despite limited data on mortality outcomes 1. The key to successful therapy is finding the minimum effective dose that maintains euvolemia while minimizing adverse effects on renal function and electrolyte balance 2.